218 related articles for article (PubMed ID: 5978335)
21. [Sex chromatin as a criterion for the treatment of breast cancer].
Bruskin IaM
Khirurgiia (Mosk); 1975 Feb; (2):18-22. PubMed ID: 1113466
[No Abstract] [Full Text] [Related]
22. [Single stage ovaro-adrenalectomy in the treatment of cancer of the breast].
Caluzzi F; Calvi A; Diurni M
Minerva Med; 1979 Mar; 70(16):1155-8. PubMed ID: 440586
[No Abstract] [Full Text] [Related]
23. [Internal therapy of metastasizing breast cancer].
Strik WO; Pusch H; Liebscher W
Med Welt; 1973 Aug; 24(33):1261-5. PubMed ID: 4764440
[No Abstract] [Full Text] [Related]
24. [Endocrine treatment of metastasis of breast cancers].
GANDAR R
Strasb Med; 1962 Jun; 13():435-45. PubMed ID: 13896604
[No Abstract] [Full Text] [Related]
25. Hormonal therapy of carcinoma of the breast.
BECK JC
Can Serv Med J; 1957 Oct; 13(9):607-13. PubMed ID: 13472595
[No Abstract] [Full Text] [Related]
26. [Hormones and tumor therapy: current clinical status and future developments in endocrine therapy of breast cancer].
Szepesi T; Schratter-Sehn AU
Wien Klin Wochenschr; 1982 Sep; 94(17):463-9. PubMed ID: 6760557
[TBL] [Abstract][Full Text] [Related]
27. [Endocrine treatment of metastatic cancer of breast and prostate].
LUFT R; OLIVECRONA H; IKKOS D
Nord Med; 1957 Jan; 57(4):127-30. PubMed ID: 13419106
[No Abstract] [Full Text] [Related]
28. Sex chromatin pattern in patients with advanced cancer breast.
El-Sayed Ahmed L; Hammouda F; Tawfik HN; Raafat M; Sami A
J Egypt Med Assoc; 1976; 59(3-4):287-97. PubMed ID: 1032146
[No Abstract] [Full Text] [Related]
29. Systemic therapy for breast cancer: changing trends, 1980.
Vogel CL
Compr Ther; 1980 Oct; 6(10):48-53. PubMed ID: 7449365
[No Abstract] [Full Text] [Related]
30. [The current status of endocrine therapy in the palliative treatment of the metastasizing breast carcinoma in women].
Nowakowski H
Chirurg; 1968 Jun; 39(6):258-63. PubMed ID: 5697277
[No Abstract] [Full Text] [Related]
31. [Chemotherapy in breast neoplasms. A review].
Pedersen H; Larsen V
Ugeskr Laeger; 1976 Jun; 138(24):1445-9. PubMed ID: 1273972
[No Abstract] [Full Text] [Related]
32. [Endocrine surgery for metastatic breast carcinoma].
Catania VC; Pizzocaro G; Salvadori B
Osp Ital Chir; 1970 Jan; 22(1):7-12. PubMed ID: 4099021
[No Abstract] [Full Text] [Related]
33. Bilateral adrenalectomy for advanced female breast cancer.
Wawro NW; Mukerji MJ; Deren M
Conn Med; 1977 Feb; 41(2):67-70. PubMed ID: 837674
[No Abstract] [Full Text] [Related]
34. Cancer of the breast. Endocrine ablation, hormone therapy and chemotherapy.
Donegan WL
Major Probl Clin Surg; 1967; 5():201-44. PubMed ID: 5005673
[No Abstract] [Full Text] [Related]
35. Biochemical basis for the selection of hormonal manipulation in the patient with breast carcinoma.
Wittliff JL; Savlov ED
Int J Radiat Oncol Biol Phys; 1978; 4(5-6):463-7. PubMed ID: 689947
[No Abstract] [Full Text] [Related]
36. [Ovariectomy with bilateral adrenalectomy for advanced cancer of the breast. 118 cases].
Caldarola L; Badellino F; Molinatti GM
Presse Med (1893); 1971 Sep; 79(40):1743-4. PubMed ID: 5120819
[No Abstract] [Full Text] [Related]
37. Status of adrenalectomy in the treatment of metastatic breast cancer. A review of 84 patients.
Harris HS; Donegan WL; Spratt JS
Mo Med; 1972 Jan; 69(1):47-52. PubMed ID: 5007337
[No Abstract] [Full Text] [Related]
38. Endocrine control of advanced breast cancer.
HOLLANDER VP
Va Med Mon (1918); 1957 Mar; 84(3):128-30. PubMed ID: 13409754
[No Abstract] [Full Text] [Related]
39. Estrogen receptor: a valid test for selection of breast cancer patients for endocrine ablation.
Leung BS; Fletcher WS; Krippaehne WW
Surg Forum; 1973; 24():125-7. PubMed ID: 4142813
[No Abstract] [Full Text] [Related]
40. [Ovaro-adrenalectomy and hypophysial radiosideration in metastatized cancer of the breast: considerations on the behavior of urinary steroids].
CATANIA VC; LADO P
Tumori; 1961; 47():32-51. PubMed ID: 13877311
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
